Vertellus shares insight on Hollow Fibre Membranes (HFM) in biopharmaceuticals and how it became a crucial part of the biotech industry’s value chain in recent years.
Luc Gagnon, vice president of vaccine sciences at Nexelis, gives an insight into the increase in vaccine hesitancy and the role that pharmaceutical and R&D industries need to take to address the problem.
Withers & Rogers gives an insight into the new ways that AI is helping to accelerate drug discovery and highlights the challenges that exist when bringing such innovations to market.
Following on from their recent partnership with Israel Biotech Fund (IBF), EPM caught up with Lonza's Pnina Weitz on the importance of early-stage support for emerging companies, and how robust strategies early on can pave a way to commercialisation.
Terumo Pharmaceutical Solutions (TPS), a manufacturer of injection, primary container, and infusion therapy devices, has launched a pre-fillable polymer syringe for low dose applications such as ophthalmic drugs.
Insights from David Budd, CEO of genedrive, on the advances in pharmacogenetic testing technology to maintain quality of care and treatment optimisation in acute medical settings.
Alan Ryan, managing director at Technoprint, explains the challenges that printing businesses face in supplying the pharmaceutical industry and the medicine needed to solve them.
In this study, organic solutions and aqueous dispersions of ethylcellulose (EC) were used to prepare a prolonged drug release dosage form consisting of a single dose of drug subdivided into many small units.
Martin Stocks, CEO of Iceni Glycoscience, discusses how preparedness for the pandemic relies on leveraging the technologies and insights of innovative startups.
EPM editor and first-time attendee to Pharmapack, Rebekah Jordan, reflects on some of the exhibitors and innovations that stood out at this year’s Pharmapack Paris event 2022.
In a keynote session at CPHI North America, Stephanie Gaulding, executive director of regulatory compliance at Pharmatech Associates, calls for innovators to look closely at the frameworks they agree to and work to mitigate future challenges.
